4.8 Article

A programmed surface on polyetheretherketone for sequentially dictating osteoimmunomodulation and bone regeneration to achieve ameliorative osseointegration under osteoporotic conditions

Journal

BIOACTIVE MATERIALS
Volume 14, Issue -, Pages 364-376

Publisher

KEAI PUBLISHING LTD
DOI: 10.1016/j.bioactmat.2022.01.042

Keywords

Polyetheretherketone; Surface modification; Osteoimmunomodulation; Sequential release; Osteoporosis; Osseointegration

Funding

  1. National Natural Science Foundation of China [31922040, 82001965]
  2. Shenzhen Science and Technology Research Funding [SGLH20180625144002074, JCYJ20180507182637685, JCYJ20190806165616542]
  3. Youth Innovation Promotion Association of Chinese Academy of Sciences [2017416, 2020353]
  4. Guangdong Basic and Applied Basic Research Foundation [2020B1515120078]
  5. China Postdoctoral Science Foundation [2019M663190]
  6. SIAT Innovation Program for Excellent Young Researchers [E1G034]
  7. Nanchong Science and Technology Project [20SXQT0302]
  8. City University of Hong Kong Strategic Research Grant (SRG) [7005505]

Ask authors/readers for more resources

This article introduces a method to design and fabricate a programmable surface on PEEK to sequentially regulate osteoimmunomodulation and bone regeneration, improving the osseointegration of bone implants, especially under osteoporotic conditions.
Polyetheretherketone (PEEK) is a desirable alternative to conventional biomedical metals for orthopedic implants due to the excellent mechanical properties. However, the inherent bioinertness of PEEK contributes to inferior osseointegration of PEEK implants, especially under pathological conditions of osteoporosis. Herein, a programmed surface is designed and fabricated on PEEK to dictate osteoimmunomodulation and bone regeneration sequentially. A degradable hybrid coating consisting of poly(lactide-co-glycolide) and alendronate (ALN) loaded nano-hydroxyapatite is deposited on PEEK and then interleukin-4 (IL-4) is grafted onto the outer surface of the hybrid coating with the aid of N-2 plasma immersion ion implantation and subsequent immersion in IL-4 solution. Dominant release of IL-4 together with ALN and Ca2+ during the first few days synergistically mitigates the early acute inflammatory reactions and creates an osteoimmunomodulatory microenvironment that facilitates bone regeneration. Afterwards, slow and sustained delivery of ALN and Ca2+ in the following weeks boosts osteogenesis and suppresses osteoclastogenesis simultaneously, consequently ameliorating bone-implant osseointegration even under osteoporotic conditions. By taking into account the different phases in bone repair, this strategy of constructing advanced bone implants with sequential functions provides customizable and clinically viable therapy to osteoporotic patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available